Darmstadt, Germany

Britta Sundermann

This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Britta Sundermann. Retrieved from https://idiyas.com/inventor/britta-sundermann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Britta Sundermann: Innovator in Biotech

Introduction

Britta Sundermann is a prominent inventor based in Darmstadt, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and polynucleotides.

Latest Patents

Sundermann holds a patent for Seripancrin, which involves Seripancrin polypeptides and polynucleotides. The patent details methods for producing these polypeptides through recombinant techniques. Additionally, it outlines methods for utilizing Seripancrin polypeptides and polynucleotides in diagnostic assays. She has 1 patent to her name.

Career Highlights

Britta Sundermann is currently employed at Merck Patent GmbH, where she continues to advance her research and innovation in biotechnology. Her work has been instrumental in enhancing diagnostic methods and therapeutic applications.

Collaborations

Sundermann collaborates with notable colleagues, including Uwe Hofmann and Siegfried Matzku, who contribute to her research endeavors.

Conclusion

Britta Sundermann is a key figure in the biotechnology sector, with her innovative work on Seripancrin paving the way for advancements in diagnostics and therapeutics. Her contributions are vital to the ongoing evolution of biotechnological applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…